Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27959985 | 1.00 | TRPA1 (0.30) | TRPA1TRPM8 | |
| SCHEMBL28148440 | 0.87 | GPBAR1 (0.32) | TRPA1TRPM8 | |
| SCHEMBL27801263 | 0.87 | TRPA1 (0.31) | TRPA1TRPM8 | |
| SCHEMBL27875446 | 0.86 | TRPA1 (0.30) | TRPA1TRPM8 | |
| SCHEMBL27668512 | 0.86 | TRPA1 (0.30) | TRPA1TRPM8 | |
| SCHEMBL28289084 | 0.86 | EP300 (0.33) | TRPA1TRPM8 | |
| SCHEMBL27642076 | 0.86 | TRPA1 (0.30) | TRPA1TRPM8 | |
| SCHEMBL9617897 | 0.84 | MGAM (0.31) | — | |
| SCHEMBL27164906 | 0.84 | — | — | |
| SCHEMBL8644392 | 0.83 | TSHR (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102516078-A | Preparation methods of glyoxylic acid L-menthyl alcohol ester and monohydrate of glyoxylic acid L-menthyl alcohol ester | ZHEJIANG XIANFENG TECHNOLOGIES CO LTD | 2012-06-27 | — | — | CN | disclosed |
| US-7498431-B2 | Process for the preparation of chiral azetidinones | FRAMROZE BOMI PATEL | 2009-03-03 | — | — | US | disclosed |
| US-20070129540-A1 | Process for the preparation of chiral azetidinones | OPUS ORGANICS PVT LIMITED (IN) | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129540-A1 | Process for the preparation of chiral azetidinones | CYP1B1, ALDH7A1, CYP3A5 | TRPA1 4696/4885TRPM8 4877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.